Evaluation of adverse events focusing on infection associated with infliximab originator and biosimilar using a spontaneous reporting system database

Evaluation of adverse events focusing on infection associated with infliximab originator and biosimilar using a spontaneous reporting system database

Abstract Background Infliximab (IFX) has changed the management of many life-threatening immune-mediated diseases. The high cost of IFX and its patent expiry have led to pharmaceutical companies developing a biosimilar; however, its safety profile remains unknown in the real world. The purpose of th...

Full description

Bibliographic Details
Main Authors:	Iku Niinomi, Keiko Hosohata, Yasuhiro Mori, Yuki Yamaguchi, Tomohito Wakabayashi, Mayako Uchida, Kazunori Iwanaga
Format:	Article
Language:	English
Published:	BMC 2019-10-01
Series:	Journal of Pharmaceutical Health Care and Sciences
Subjects:	Biosimilar Infliximab Adverse drug events Spontaneous reporting system Reporting odds ratio (ROR) Japanese Adverse Drug Event Report (JADER) database
Online Access:	http://link.springer.com/article/10.1186/s40780-019-0149-z

Similar Items

Comparison of Adverse Event Profiles of Tumor Necrosis Factor-Alfa Inhibitors: Analysis of a Spontaneous Reporting Database
by: Wakabayashi T, et al.
Published: (2020-08-01)

Drug-induced tubulointerstitial nephritis in a retrospective study using spontaneous reporting system database
by: Oyama S, et al.
Published: (2018-09-01)

Comprehensive Analysis of Adverse Events Induced by PARP Inhibitors Using JADER and Time to Onset
by: Kenta Yamaoka, et al.
Published: (2022-08-01)

A Standardized Dataset of a Spontaneous Adverse Event Reporting System
by: Mohammad Ali Khaleel, et al.
Published: (2022-02-01)

Pituitary-Related Adverse Events and Onset Patterns Caused by Immune Checkpoint Inhibitors: Analysis Using the Japanese Adverse Drug Event Report Database
by: Hiroki Asano, et al.
Published: (2023-11-01)

Exploring the Mechanisms Underlying Drug-Induced Fractures Using the Japanese Adverse Drug Event Reporting Database
by: Shinya Toriumi, et al.
Published: (2021-12-01)

Characteristics and Spectrum of Cardiotoxicity Induced by Various Antipsychotics: A Real-World Study From 2015 to 2020 Based on FAERS
by: Luyao He, et al.
Published: (2022-02-01)

Examination of Risk Factors and Expression Patterns of Atypical Femoral Fractures Using the Japanese Adverse Drug Event Report Database: A Retrospective Pharmacovigilance Study
by: Shinya Toriumi, et al.
Published: (2023-04-01)

Analysis of Corticosteroid-Induced Glaucoma Using the Japanese Adverse Drug Event Reporting Database
by: Ayano Kawabe, et al.
Published: (2023-06-01)

Analysis of drug-induced interstitial lung disease caused by herbal medicine using the Japanese Adverse Drug Event Report database
by: Keita Oura, et al.
Published: (2024-03-01)

Analyses of non-benzodiazepine-induced adverse events and prognosis in elderly patients based on the Japanese adverse drug event report database
by: Yoshihiro Noguchi, et al.
Published: (2018-05-01)

A Pharmacovigilance Study of Drug-Induced Glaucoma Utilizing the Japanese Adverse Event Reporting System
by: Kozaru M, et al.
Published: (2023-11-01)

Adverse Event Profiles of PARP Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS
by: Xiaojiang Tian, et al.
Published: (2022-03-01)

Frequency of Immune Checkpoint Inhibitor-Induced Vasculitides: An Observational Study Using Data From the Japanese Adverse Drug Event Report Database
by: Koki Kato, et al.
Published: (2022-03-01)

Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database
by: Aoi Noda, et al.
Published: (2020-05-01)

Identifying Crude Drugs in Kampo Medicines Associated with Drug-Induced Liver Injury Using the Japanese Adverse Drug Event Report Database: A Comprehensive Survey
by: Kyosuke Kimura, et al.
Published: (2023-05-01)

Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database
by: Haruna Hatahira, et al.
Published: (2018-12-01)

Pharmacovigilance study of anti-infective-related acute kidney injury using the Japanese adverse drug event report database
by: Satoshi Nakao, et al.
Published: (2021-08-01)

Comprehensive Study of the Risk Factors for Medication-Related Osteonecrosis of the Jaw Based on the Japanese Adverse Drug Event Report Database
by: Shinya Toriumi, et al.
Published: (2020-12-01)

Analysis of Opioid-Related Adverse Events in Japan Using FAERS Database
by: Risako Hirai, et al.
Published: (2023-11-01)

Analysis of Adverse Drug Reaction Reports from a Public Hospital in Shanxi Province in 2022
by: Zhang XJ, et al.
Published: (2023-08-01)

Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
by: Eirini Theodoraki, et al.
Published: (2021-10-01)

Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting system
by: Xue-Feng Jiao, et al.
Published: (2023-01-01)

Prevalence rate of spontaneously reported adverse events and determinants of serious adverse events amongst three outpatient care settings in ghana: findings and implications
by: Israel Abebrese Sefah, et al.
Published: (2021-01-01)

Adverse event reporting practices in drug-resistant tuberculosis facilities across South Africa
by: Razia Gaida, et al.
Published: (2023-12-01)

Infusion reaction to infliximab biosimilar after transitioning from infliximab
by: Reem Kashlan, MPH, et al.
Published: (2021-02-01)

Three aspects of acupuncture-related adverse events: Issues around the reporting of acupuncture-related adverse events
by: Tae-Hun Kim, et al.
Published: (2023-09-01)

Verification of the “Upward Variation in the Reporting Odds Ratio Scores” to Detect the Signals of Drug–Drug Interactions
by: Yoshihiro Noguchi, et al.
Published: (2021-09-01)

Epirubicin and gait apraxia: a real-world data analysis of the FDA Adverse Event Reporting System database
by: Wei Wang, et al.
Published: (2023-09-01)

Investigation of the characteristics of medication errors and adverse drug reactions using pharmacovigilance data in China
by: Xiaofang Tan, et al.
Published: (2020-10-01)

Pharmacovigilance in Serbia: a Ten-Year Pharmacoepidemiologic Analysis
by: Dejan Živanović, et al.
Published: (2023-01-01)

Adherence patterns in naïve and prevalent use of infliximab and its biosimilar
by: Chibuike J. Alanaeme, et al.
Published: (2022-11-01)

Treatment persistence during therapeutic sequences with adalimumab and infliximab in the treatment of Crohn's disease
by: Carlos Taxonera, et al.

Gender differences in spontaneous adverse event reports associated with zolpidem in South Korea, 2015–2019
by: Kyung-In Joung
Published: (2023-11-01)

Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients
by: Bas J. M. Peters, et al.
Published: (2021-02-01)

Psychiatric Adverse Events Associated With Infliximab: A Cohort Study From the French Nationwide Discharge Abstract Database
by: Eve-Marie Thillard, et al.
Published: (2020-04-01)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
by: Han N, et al.
Published: (2021-08-01)

Study of adverse drug reactions in out-patient departments of a teaching hospital
by: Zinnat Ara Begum, et al.
Published: (2012-06-01)

Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database
by: Zhi-Xuan Zhou, et al.
Published: (2022-04-01)

Safety of interferon β-1a for treatment of COVID-19： a real-world study based on FAERS database
by: YANG Rongqing, et al.
Published: (2023-06-01)